(M2 EQUITYBITES via COMTEX) -- Therapeutic products company Anika Therapeutics Inc (NASDAQ: ANIK | PowerRating) reported on Thursday the appointment of Jeffery S. Thompson to its board of directors.
This increases the number of board seats to seven.
Currently Thompson serves as chairman and chief executive officer of Advanced Bio-Technologies Inc (ABT), a Georgia-based biopharmaceutical company that specialises in the treatment and management of scars. He is also an operating partner for private equity firm HealthEdge Investment Partners and chairman of the board at Woodbury Products, a distributor of incontinence and related healthcare products.
Previously Thompson was chief operating officer at Stiefel Laboratories Inc, where he was also a member of the board of directors until the company’s acquisition by GlaxoSmithKline.
Comments on this story may be sent to info@m2.com
For full details on Anika Therapeutics Inc (ANIK) ANIK. Anika Therapeutics Inc (ANIK) has Short Term PowerRatings at TradingMarkets. Details on Anika Therapeutics Inc (ANIK) Short Term PowerRatings is available at This Link.
